ArticleJournal of hematology & oncology2024
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel.
Saurabh Zanwar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled ittrialcites it